Use of Epigenetic Cell Counting to Determine the Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis Carlos Bonilla2021-12-06T11:29:50-05:00Resources| Read More
Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay Carlos Bonilla2021-11-29T17:36:51-05:00Resources| Read More
Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-associated Mechanisms of Action Carlos Bonilla2021-11-29T17:35:58-05:00Resources| Read More
Quantifying Circulating Th17 Cells by qPCR: Potential as Diagnostic Biomarker for Rheumatoid Arthritis Carlos Bonilla2021-11-29T17:07:24-05:00Resources| Read More
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci Carlos Bonilla2021-12-06T11:27:52-05:00Resources| Read More
Effect of the Sphingosine-1-phosphate Receptormodulator Ozanimod on Leukocyte Subtypes Inrelapsing MS Carlos Bonilla2021-11-29T17:18:05-05:00Resources| Read More
Epigenetic Immune Cell Counting in Human Blood Samples for Immunodiagnostics Carlos Bonilla2021-12-06T11:34:04-05:00Resources| Read More
Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy Carlos Bonilla2021-12-07T16:51:58-05:00Resources| Read More
Regulatory T Cells Are Not a Strong Predictor of Survival For Patients With Glioblastoma Carlos Bonilla2021-11-29T17:12:15-05:00Resources| Read More
Epigenetically Quantified Immune Cells in Salivary Glands of Sjögren’s Syndrome Patients: A Novel Tool That Detects Robust Correlations of T Follicular Helper Cells With Immunopathology Carlos Bonilla2021-12-06T11:34:31-05:00Resources| Read More
